SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-006822
Filing Date
2019-03-07
Accepted
2019-03-07 16:47:55
Documents
4
Period of Report
2019-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acer-8k_20190301.htm 8-K 40851
2 EX-16.1 acer-ex161_74.htm EX-16.1 4378
3 EX-99.1 acer-ex991_73.htm EX-99.1 196034
4 GRAPHIC gylgywhqu3zs000001.jpg GRAPHIC 2729
  Complete submission text file 0001564590-19-006822.txt   246874
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 19666449
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1